Cargando…
Mortality and pre‐hospitalization use of low‐dose aspirin in COVID‐19 patients with coronary artery disease
To determine whether pre‐hospitalization use of aspirin is associated with all‐cause mortality in coronavirus disease 2019 (COVID‐19) patients with coronary artery disease (CAD). We recruited 183 adult patients with CAD diagnosed with COVID‐19, including 52 taking low‐dose aspirin (mean [SD] age, 69...
Autores principales: | Yuan, Shuai, Chen, Peng, Li, Huaping, Chen, Chen, Wang, Feng, Wang, Dao Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812246/ https://www.ncbi.nlm.nih.gov/pubmed/33336936 http://dx.doi.org/10.1111/jcmm.16198 |
Ejemplares similares
-
Application of low dose aspirin in pre-eclampsia
por: Ren, Yu, et al.
Publicado: (2023) -
The role of low-dose aspirin in the prevention of pre-eclampsia
por: Akhigbe, R. E.
Publicado: (2014) -
Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19
por: Liu, Qiang, et al.
Publicado: (2021) -
Effects of low-dose aspirin in subjects with dyslipidemia
por: Lou, Guozhong, et al.
Publicado: (2016) -
Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
por: Qu, Jianyu, et al.
Publicado: (2021)